78 related articles for article (PubMed ID: 7992361)
1. One-year enzyme-linked immunosorbent assay follow-up of human interleukin for Da cells/leukemia inhibitory factor in blood and urine of 22 kidney transplant recipients.
Morel D; Taupin JL; Combe C; Potaux L; Gualde N; Moreau JF
Transplantation; 1994 Dec; 58(11):1190-5. PubMed ID: 7992361
[TBL] [Abstract][Full Text] [Related]
2. HILDA/LIF urinary excretion during acute kidney rejection.
Taupin JL; Morel D; Moreau JF; Gualde N; Potaux L; Bezian JH
Transplantation; 1992 Mar; 53(3):655-8. PubMed ID: 1549861
[TBL] [Abstract][Full Text] [Related]
3. HILDA/LIF is present in the urine of rejecting kidney graft recipients.
Blancho G; Moreau JF; Anegon I; Soulillou JP
Transpl Int; 1992 Mar; 5(1):57-8. PubMed ID: 1580988
[No Abstract] [Full Text] [Related]
4. Human interleukin DA-1a (HILDA)/LIF,G-CSF, IL-1 beta, IL-6, and TNF alpha production during acute kidney graft rejection episodes.
Blancho G; Moreau JF; Chabannes D; Chatenoud L; Soulillou JP
Transplant Proc; 1993 Feb; 25(1 Pt 2):891-2. PubMed ID: 7680169
[No Abstract] [Full Text] [Related]
5. HILDA/LIF, G.CSF, IL-1 beta, IL-6, and TNF alpha production during acute rejection of human kidney allografts.
Blancho G; Moreau JF; Chabannes D; Chatenoud L; Soulillou JP
Transplantation; 1993 Sep; 56(3):597-602. PubMed ID: 7692628
[TBL] [Abstract][Full Text] [Related]
6. Leukemia inhibitory factor concentrations in the bone marrow plasma of healthy subjects and patients with hematologic malignancies.
Lorgeot V; Trimoreau F; Gachard N; Praloran V; Denizot Y
Eur Cytokine Netw; 1997 Mar; 8(1):57-9. PubMed ID: 9110149
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of leukaemia inhibitory factor (LIF) in urine and tissue culture supernatant from human primary bone tumours.
Gouin F; Heymann D; Raher S; De Groote D; Passuti N; Daculsi G; Godard A
Cytokine; 1998 Feb; 10(2):110-4. PubMed ID: 9512900
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody based elisa for quantitation of human leukaemia inhibitory factor.
Taupin JL; Gualde N; Moreau JF
Cytokine; 1997 Feb; 9(2):112-8. PubMed ID: 9071562
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis.
Villers D; Dao T; Nguyen JM; Bironneau E; Godard A; Moreau M; De Groote D; Nicolas F; Soulillou JP; Anegon I
J Infect Dis; 1995 Jan; 171(1):232-6. PubMed ID: 7798671
[TBL] [Abstract][Full Text] [Related]
10. Renal synthesis of leukaemia inhibitory factor (LIF), under normal and inflammatory conditions.
Morel DS; Taupin JL; Potier M; Deminière C; Potaux L; Gualde N; Moreau JF
Cytokine; 2000 Mar; 12(3):265-71. PubMed ID: 10704254
[TBL] [Abstract][Full Text] [Related]
11. Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues.
Gascan H; Anegón I; Praloran V; Naulet J; Godard A; Soulillou JP; Jacques Y
J Immunol; 1990 Apr; 144(7):2592-8. PubMed ID: 2156925
[TBL] [Abstract][Full Text] [Related]
12. Analysis of interleukin-6, interleukin-10 and leukemia inhibitory factor (LIF) production by peripheral blood cells from patients with systemic lupus erythematosus identifies LIF as a potential marker of disease activity.
Viallard JF; Taupin JL; Miossec V; Pellegrin JL; Moreau BL
Eur Cytokine Netw; 1999 Mar; 10(1):17-24. PubMed ID: 10210768
[TBL] [Abstract][Full Text] [Related]
13. Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells.
Moreau JF; Donaldson DD; Bennett F; Witek-Giannotti J; Clark SC; Wong GG
Nature; 1988 Dec; 336(6200):690-2. PubMed ID: 3143918
[TBL] [Abstract][Full Text] [Related]
14. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
Wetzler M; Estrov Z; Talpaz M; Kim KJ; Alphonso M; Srinivasan R; Kurzrock R
Cancer Res; 1994 Apr; 54(7):1837-42. PubMed ID: 8137298
[TBL] [Abstract][Full Text] [Related]
15. High levels of leukaemia inhibitory factor in ARDS.
Jorens PG; De Jongh R; Bossaert LL; De Backer W; Herman AG; Pollet H; Bosmans E; Taupin JL; Moreau JF
Cytokine; 1996 Nov; 8(11):873-6. PubMed ID: 9047084
[TBL] [Abstract][Full Text] [Related]
16. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
Wierzbowska A; Urbańska-Ryś H; Robak T
Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
[TBL] [Abstract][Full Text] [Related]
17. Generation of monoclonal antibodies against HILDA/LIF and their use in the quantitative assay of the cytokine.
Godard A; Fauchet F; Raher S; Jadoul M; Thuillier B; Dehart J; Soulillou JP; Baudrihaye M; Jacques Y; De Groote D
Cytokine; 1993 Jan; 5(1):16-23. PubMed ID: 8485303
[TBL] [Abstract][Full Text] [Related]
18. Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-alpha.
Jansen PM; de Jong IW; Hart M; Kim KJ; Aarden LA; Hinshaw LB; Taylor FB; Hack CE
J Immunol; 1996 Jun; 156(11):4401-7. PubMed ID: 8666813
[TBL] [Abstract][Full Text] [Related]
19. In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids.
Grosset C; Jazwiec B; Taupin JL; Liu H; Richard S; Mahon FX; Reiffers J; Moreau JF; Ripoche J
Blood; 1995 Nov; 86(10):3763-70. PubMed ID: 7579343
[TBL] [Abstract][Full Text] [Related]
20. Leukaemia inhibitory factor is expressed by normal human keratinocytes in vitro and in vivo.
Paglia D; Kondo S; Ng KM; Sauder DN; McKenzie RC
Br J Dermatol; 1996 May; 134(5):817-23. PubMed ID: 8736319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
